Disparities in the burden, outcomes, and care of chronic kidney disease

Current Opinion in Nephrology and Hypertension

Volumn 23, Issue 3, 2014, Pages 298-305

  Crews, Deidra C ^a,b   Liu, Yang ^a,b   Boulware, L Ebony ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ethnicity; kidney transplantation; race; renal; socioeconomic status

Indexed keywords

ALBUMIN; APOLIPOPROTEIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN;

ALBUMIN BLOOD LEVEL; ALBUMINURIA; APOLIPOPROTEIN L1 GENE; CAUCASIAN; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; EDUCATIONAL STATUS; END STAGE RENAL DISEASE; ETHNIC DIFFERENCE; FOLLOW UP; GENE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE FACILITY; HEALTH DISPARITY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HEREDITY; HISPANIC; HUMAN; INCIDENCE; INCOME; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; MEDICAID; MEDICARE; MORTALITY; NEGRO; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RACE DIFFERENCE; RESIDENTIAL AREA; REVIEW; SOCIAL STATUS; ANCESTRY GROUP; DEMOGRAPHY; ETHNIC GROUP; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; HEALTH CARE DELIVERY; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; TREATMENT OUTCOME;

CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; KIDNEY TRANSPLANTATION; PREVALENCE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; RISK FACTORS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 84898542107     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/01.mnh.0000444822.25991.f6     Document Type: Review

References (42)

1. Hossain MP, Goyder EC, Rigby JE, El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis 2009; 53:166-174.
2. Nicholas SB, Kalantar-Zadeh K, Norris KC. Racial disparities in kidney disease outcomes. Semin Nephrol 2013; 33:409-415.
3. Crews DC, Pfaff T, Powe NR. Socioeconomic factors and racial disparities in kidney disease outcomes. Semin Nephrol 2013; 33:468-475.
4. Amaral S, Patzer RE, Kutner N, McClellan W. Racial disparities in access to pediatric kidney transplantation since share 35. J Am Soc Nephrol 2012; 23:1069-1077.
5. U.S. Renal Data System. USRDS 2012 annual data report: atlas of endstage renal disease in the United States: National Institutes of Health. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Disease; 2012 .
6. Young EW, Mauger EA, Jiang KH, et al. Socioeconomic status and end-stage renal disease in the United States. Kidney Int 1994; 45:907-911.
7. Volkova N, McClellan W, Klein M, et al. Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol 2008; 19:356-364.
8. Crews DC, Charles RF, Evans MK, et al. Poverty, race, and CKD in a racially and socioeconomically diverse urban population. Am J Kidney Dis 2013; 55:992-1000.
9. Crews DC, McClellan WM, Shoham DA, et al. Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants. Am J Kidney Dis 2012; 60:779-786.
10. Tanner RM, Gutierrez OM, Judd S, et al. Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Kidney Dis 2013; 61:395-403.
11. Smith DH, Gullion CM, Nichols G, et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004; 15:1300-1306.
12. Plantinga L, Howard VJ, Judd S, et al. Association of duration of residence in the southeastern United States with chronic kidney disease may differ by race: the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study. Int J Health Geogr 2013; 12:17.
13. Barker LE, Kirtland KA, Gregg EW, et al. Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt. Am J Prev Med 2011; 40:434-439.
14. Howard VJ, Woolson RF, Egan BM, et al. Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens 2010; 4:32-41.
15. Glymour MM, Kosheleva A, Boden-Albala B. Birth and adult residence in the Stroke Belt independently predict stroke mortality. Neurology 2009; 73:1858-1865.
16. Bruce MA, Beech BM, Sims M, et al. Social environmental stressors, psychological factors, and kidney disease. J Invest Med 2009; 57:583-589.
17. Usami T, Koyama K, Takeuchi O, et al. Regional variations in the incidence of end-stage renal failure in Japan. JAMA 2000; 284:2622-2624.
18. Usami T, Nakao N, Fukuda M, et al. Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan. Kidney Int 2003; 64:1445-1449.
19. Wakamatsu-Yamanaka T, Fukuda M, Sato R, et al. Geographic differences in the increasing ESRD rate have disappeared in Japan. Clin Exp Nephrol 2011; 15:708-713.
20. Vart P, Gansevoort RT, Coresh J, et al. Socioeconomic measures and CKD in the United States and the Netherlands. Clin J Am Soc Nephrol 2013; 8:1685-1693.
21. Parsa A, Kao WH, Xie D, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013; 369:2183-2196.
22. Pollak MR, Genovese G, Friedman DJ. APOL1 and kidney disease. Curr Opin Nephrol Hypertens 2012; 21:179-182.
23. Friedman DJ, Kozlitina J, Genovese G, et al. Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol 2011; 22:2098-2105.
24. Foster MC, Coresh J, Fornage M, et al. APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol 2013; 24:1484-1491.
25. Williams WW, Pollak MR. Health disparities in kidney disease - emerging data from the human genome. N Engl J Med 2013; 369:2260-2261.
26. Divers J, Nunez M, High KP, et al. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy. Kidney Int 2013; 8:1207-1213
27. Derose SF, Rutkowski MP, Crooks PW, et al. Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Am J Kidney Dis 2013; 62:236-244.
28. Kovesdy CP, Quarles LD, Lott EH, et al. Survival advantage in black versus white men with CKD: effect of estimated GFR and case mix. Am J Kidney Dis 2013; 62:228-235.
29. Chang TI, Li S, Chen SC, et al. Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2013; 61:S4-S11.
30. Gutierrez OM, Khodneva YA, Muntner P, et al. Association between urinary albumin excretion and coronary heart disease in black vs white adults. JAMA 2013; 310:706-714.
31. Hall YN, Choi AI, Xu P, et al. Predictors of end-stage renal disease in the urban poor. J Health Care Poor Underserved 2013; 24:1686-1700.
32. Samuel SM, Palacios-Derflingher L, Tonelli M, et al. Association between First Nations ethnicity and progression to kidney failure by presence and severity of albuminuria. CMAJ 2014; 186:E86-E94; doi: 10.1503/cmaj.130776. [Epub ahead of print]
33. Shah BR, Gunraj N, Hux JE. Markers of access to and quality of primary care for aboriginal people in Ontario, Canada. Am J Public Health 2003; 93:798-802.
34. Gao S, Manns BJ, Culleton BF, et al. Access to healthcare among status Aboriginal people with chronic kidney disease. CMAJ 2008; 179:1007-1012.
35. Van den Beukel TO, de Goeij MC, Dekker FW, et al. Differences in progression to ESRD between black and white patients receiving predialysis care in a Universal Healthcare System. Clin J Am Soc Nephrol 2013; 8:1540-1547.
36. Kimmel PL, Fwu CW, Eggers PW. Segregation, income disparities, and survival in hemodialysis patients. J Am Soc Nephrol 2013; 24:293-301.
37. Franco M, Diez Roux AV, Glass TA, et al. Neighborhood characteristics and availability of healthy foods in Baltimore. Am J Prev Med 2008; 35:561-567.
38. Hall YN, Xu P, Chertow GM, Himmelfarb J. Characteristics and performance of minority-serving dialysis facilities. Health Serv Res 2013; doi: 10.1111/ 1475-6773.12144. [Epub ahead of print]
39. Grace BS, Clayton PA, Cass A, McDonald SP. Transplantation rates for livingbut not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney Int 2013; 83:138-145.
40. Gill J, Dong J, Rose C, et al. The effect of race and income on living kidney donation in the United States. J Am Soc Nephrol 2013; 24:1872-1879.
41. Promislow S, Hemmelgarn B, Rigatto C, et al. Young aboriginals are less likely to receive a renal transplant: a Canadian national study. BMC Nephrol 2013; 14:11.
42. Joshi S, Gaynor JJ, Bayers S, et al. Disparities among blacks, Hispanics, and whites in time from starting dialysis to kidney transplant waitlisting. Transplantation 2013; 95:309-318. Diseases